In a poignant reminder of the often-overlooked dangers of colorectal cancer, Michael Groves’ health journey highlights an urgent need for changes in screening protocols in Canada. After experiencing abdominal pain and subsequent alarming symptoms, Groves was diagnosed with Stage 3 colorectal cancer at the age of 49. His case underscores the growing prevalence of this disease among younger adults and has prompted the Canadian Cancer Society to advocate for lowering the routine screening age from 50 to 45.
A Shocking Diagnosis
In January 2021, Groves, a resident of Ottawa, initially sought medical attention believing he had appendicitis. However, after tests ruled out that possibility, he returned home. Just days later, he noticed blood in his stool and promptly consulted his family doctor. Although the pain and bleeding subsided, his doctor scheduled a colonoscopy for April as a precaution.
“The thought that it could be colon cancer never occurred to me,” Groves recounted. After the procedure, he received the devastating news: a five-centimetre tumour had been discovered, and the cancer had metastasised to two lymph nodes. “The shock was just, like, wow, just devastating,” he said.
Despite feeling fit and running regularly, Groves was thrust into a battle with cancer, undergoing major surgery and enduring a challenging six-month chemotherapy regimen that kept him away from work for nearly nine months.
Rising Incidence Among Younger Adults
Now 54, Groves believes earlier screening could have made a significant difference in his diagnosis and treatment. His experience is becoming all too common, as the Canadian Cancer Society reports an increase in colorectal cancer diagnoses in individuals under 50.
On Wednesday, the organisation urged provincial and territorial governments to lower the recommended screening age, citing that younger adults are now two to 2.5 times more likely to receive a colorectal cancer diagnosis than in previous generations.
Brandon Purcell, advocacy manager for prevention and early detection at the Canadian Cancer Society, expressed concern over these statistics, stating, “That growth is something that’s very concerning for us, and we think that it’s time for governments to react to that so we can catch more of these cancers early.”
Current Screening Practices and Recommendations
Currently, individuals aged 50 and above undergo a fecal immunochemical test (FIT), which allows them to collect a stool sample at home and send it to a laboratory for analysis. A positive result indicates the need for a follow-up colonoscopy. Those under 50 with specific risk factors—such as a family history of colorectal cancer or visible blood in their stool—may receive proactive screening.
However, the Canadian Cancer Society suggests extending the FIT to include those aged 45 and older. Early detection significantly enhances survival rates, with figures suggesting a 90 per cent chance of survival when caught early, compared to less than 15 per cent in advanced stages.
Additionally, colonoscopies can identify precancerous polyps, which take roughly eight to ten years to evolve into cancer, highlighting the critical importance of regular screenings.
Evidence Supporting Lower Screening Age
Both the Canadian Cancer Society and Colorectal Cancer Canada have referenced a recent modelling study that bolsters the case for earlier screening. Published in the Journal of the Canadian Association of Gastroenterology, the study revealed that initiating home-based FIT testing at age 45 could prevent an estimated 15,070 colorectal cancer cases and avert 6,100 deaths over the next 45 years.
Darren Brenner, the study’s senior author and a professor at the University of Calgary, also highlighted the potential economic benefits. The research indicated that the proposed change could save $233 million in cancer treatment costs, even when accounting for the expenses associated with additional FIT tests and colonoscopies.
Why it Matters
The call to lower the colorectal cancer screening age in Canada is not merely a recommendation; it is a crucial step towards saving lives. As the prevalence of this disease escalates among younger populations, proactive measures are essential. Early detection can significantly improve survival rates and reduce the financial burden on both individuals and the healthcare system. By taking decisive action now, we can ensure that fewer Canadians face the devastating consequences of late-stage cancer diagnoses.
